Noninvasive, microbiome-based diagnosis of inflammatory bowel disease
Jiaying Zheng(Chinese University of Hong Kong), Siew C. Ng(Chinese University of Hong Kong), Çharles N. Bernstein(University of Manitoba), Jingwan Zhang(Chinese University of Hong Kong), Amy L. Hamilton(The University of Melbourne), Eugene B. Chang(University of Chicago), Whitney Tang(Chinese University of Hong Kong), David T. Rubin(University of California System), Zhilu Xu(Chinese University of Hong Kong), Qi Su(Chinese University of Hong Kong), Qianru Sun(Chinese University of Hong Kong), Mengjing Zhang(Chinese University of Hong Kong), Michael A. Kamm(The University of Melbourne), Francis K.L. Chan(Chinese University of Hong Kong), Chengyu Liu(Civil Aviation University of China), Lin Zhang(Chinese University of Hong Kong), Wenqi Lu(Chinese University of Hong Kong), Amy L Wilson O'Brien(The University of Melbourne), Chun Pan Cheung(Chinese University of Hong Kong), Jessica Ching(Chinese University of Hong Kong), Mark Morrison(The University of Queensland)
Cited by 116
Related Papers
Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations
|Nature Genetics|2015|2.8k
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
|Gastroenterology|2021|2.6k
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
|The American Journal of Gastroenterology|2015|1.8k
ACG Clinical Guideline: Ulcerative Colitis in Adults
|The American Journal of Gastroenterology|2019|1.6k
Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis
|Journal of Infection|2020|1.2k